Evaluating the cost and clinical effectiveness of long-acting, injectable aripiprazole and paliperidone palmitate once a month in a real-world setting

BACKGROUND: Antipsychotics are an effective treatment option for patients with schizophrenia and several long-acting injectables (LAIs), including risperidone, olanzapine, paliperidone, and aripiprazole are available in the UK. Treatment adherence is an issue in severe mental illness and LAIs have b...

Descripción completa

Detalles Bibliográficos
Autor principal: Hodgson, Richard E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698594/
https://www.ncbi.nlm.nih.gov/pubmed/31616168
http://dx.doi.org/10.2147/CEOR.S191198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698594/
https://www.ncbi.nlm.nih.gov/pubmed/31616168
http://dx.doi.org/10.2147/CEOR.S191198

Ejemplares similares